id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-2066,FDA,FDA-2007-D-0369,PSG_216993 - Draft Guidance on Quizartinib Dihydrochloride,Other,Guidance,2024-11-21T05:00:00Z,2024,11,2024-11-21T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:34:51Z,,1,0,09000064868293cc
FDA-2007-D-0369-2018,FDA,FDA-2007-D-0369,PSG_020833 - Draft Guidance on Fluticasone Propionate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:11Z,,1,0,0900006486829349
FDA-2007-D-0369-2060,FDA,FDA-2007-D-0369,PSG_216632 - Draft Guidance on Adapalene; Benzoyl Peroxide; Clindamycin Phosphate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-12-11T02:01:02Z,,1,0,09000064868293ca
FDA-2007-D-0369-2012,FDA,FDA-2007-D-0369,PSG_017533-Sus - Draft Guidance on Clonazepam,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:55:15Z,,1,0,0900006486829330
FDA-2007-D-0369-2013,FDA,FDA-2007-D-0369,PSG_018687 - Draft Guidance on Labetalol Hydrochloride,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:59:07Z,,1,0,0900006486829332
FDA-2007-D-0369-2021,FDA,FDA-2007-D-0369,PSG_021190 - Draft Guidance on Buspirone Hydrochloride,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:08:24Z,,1,0,0900006486829350
FDA-2007-D-0369-2022,FDA,FDA-2007-D-0369,PSG_021359 - Draft Guidance on Nitroglycerin,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:08:59Z,,1,0,0900006486829357
FDA-2007-D-0369-2057,FDA,FDA-2007-D-0369,PSG_215830 - Draft Guidance on Ritlecitinib Tosylate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:28:25Z,,1,0,09000064868293c3
FDA-2007-D-0369-2053,FDA,FDA-2007-D-0369,PSG_215179 - Draft Guidance on Pemetrexed Disodium,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:26:20Z,,1,0,09000064868293b4
FDA-2007-D-0369-2015,FDA,FDA-2007-D-0369,PSG_020281 - Draft Guidance on Tramadol Hydrochloride,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T20:00:27Z,,1,0,0900006486829336
FDA-2007-D-0369-2007,FDA,FDA-2007-D-0369,PSG_009170 - Draft Guidance on Primidone,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:52:32Z,,1,0,0900006486829323
FDA-2007-D-0369-2006,FDA,FDA-2007-D-0369,Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,Notice,Notice of Availability,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,,2024-11-21T19:50:01Z,2024-27048,0,0,0900006486829e19
FDA-2007-D-0369-2027,FDA,FDA-2007-D-0369,PSG_021641 - Draft Guidance on Rasagiline Mesylate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:11:57Z,,1,0,0900006486829361
FDA-2007-D-0369-2026,FDA,FDA-2007-D-0369,PSG_021487-ODT - Draft Guidance on Memantine Hydrochloride,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:11:26Z,,1,0,090000648682935f
FDA-2007-D-0369-2038,FDA,FDA-2007-D-0369,PSG_087954 - Draft Guidance on Phytonadione,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:18:05Z,,1,0,0900006486829381
FDA-2007-D-0369-2040,FDA,FDA-2007-D-0369,PSG_203491 - Draft Guidance on Nepafenac,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:19:09Z,,1,0,0900006486829385
FDA-2007-D-0369-2056,FDA,FDA-2007-D-0369,PSG_215559 - Draft Guidance on Palovarotene,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:27:51Z,,1,0,09000064868293c1
FDA-2007-D-0369-2051,FDA,FDA-2007-D-0369,PSG_213674 - Draft Guidance on Enzalutamide,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:25:08Z,,1,0,09000064868293a6
FDA-2007-D-0369-2064,FDA,FDA-2007-D-0369,PSG_217469 - Draft Guidance on Cyclosporine,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:33:49Z,,1,0,09000064868293de
FDA-2007-D-0369-2050,FDA,FDA-2007-D-0369,PSG_213586 - Draft Guidance on Risperidone,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:24:37Z,,1,0,09000064868293a4
FDA-2007-D-0369-2010,FDA,FDA-2007-D-0369,PSG_016084 - Draft Guidance on Allopurinol,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:54:11Z,,1,0,0900006486829329
FDA-2007-D-0369-2020,FDA,FDA-2007-D-0369,PSG_021184-Cre-0.05P - Draft Guidance on Tazarotene,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:07:46Z,,1,0,090000648682934e
FDA-2007-D-0369-2024,FDA,FDA-2007-D-0369,PSG_021470 - Draft Guidance on Azelaic Acid,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:10:13Z,,1,0,090000648682935b
FDA-2007-D-0369-2033,FDA,FDA-2007-D-0369,PSG_022341 - Draft Guidance on Liraglutide,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:15:06Z,,1,0,0900006486829376
FDA-2007-D-0369-2014,FDA,FDA-2007-D-0369,"PSG_020216 - Draft Guidance on Estrogens, Conjugated",Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-09-15T09:00:17Z,,1,0,0900006486829334
FDA-2007-D-0369-2048,FDA,FDA-2007-D-0369,PSG_211728 - Draft Guidance on Mitomycin,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-03-06T02:00:19Z,,1,0,09000064868293a0
FDA-2007-D-0369-2042,FDA,FDA-2007-D-0369,PSG_205641 - Draft Guidance on Mometasone Furoate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:11Z,,1,0,0900006486829389
FDA-2007-D-0369-2016,FDA,FDA-2007-D-0369,PSG_020692 - Draft Guidance on Salmeterol Xinafoate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:10Z,,1,0,0900006486829345
FDA-2007-D-0369-2023,FDA,FDA-2007-D-0369,PSG_021395 - Draft Guidance on Tiotropium Bromide,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:00:59Z,,1,0,0900006486829359
FDA-2007-D-0369-2049,FDA,FDA-2007-D-0369,PSG_212905 - Draft Guidance on Cantharidin,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:24:04Z,,1,0,09000064868293a2
FDA-2007-D-0369-2058,FDA,FDA-2007-D-0369,PSG_216338 - Draft Guidance on Paclitaxel,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:28:54Z,,1,0,09000064868293c5
FDA-2007-D-0369-2039,FDA,FDA-2007-D-0369,PSG_203159 - Draft Guidance on Levonorgestrel,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:18:39Z,,1,0,0900006486829383
FDA-2007-D-0369-2046,FDA,FDA-2007-D-0369,PSG_210251 - Draft Guidance on Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:22:28Z,,1,0,090000648682939c
FDA-2007-D-0369-2059,FDA,FDA-2007-D-0369,PSG_216387 - Draft Guidance on Acalabrutinib Maleate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:29:28Z,,1,0,09000064868293c7
FDA-2007-D-0369-2035,FDA,FDA-2007-D-0369,PSG_050065 - Draft Guidance on Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:16:09Z,,1,0,090000648682937a
FDA-2007-D-0369-2061,FDA,FDA-2007-D-0369,PSG_217006 - Draft Guidance on Aripiprazole,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:32:15Z,,1,0,09000064868293ce
FDA-2007-D-0369-2063,FDA,FDA-2007-D-0369,PSG_217388 - Draft Guidance on Eplontersen Sodium,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:33:17Z,,1,0,09000064868293d2
FDA-2007-D-0369-2025,FDA,FDA-2007-D-0369,PSG_021481 - Draft Guidance on Enfuvirtide,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:10:50Z,,1,0,090000648682935d
FDA-2007-D-0369-2041,FDA,FDA-2007-D-0369,PSG_203565 - Draft Guidance on Ferric Carboxymaltose,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-06-05T09:00:09Z,,1,0,0900006486829387
FDA-2007-D-0369-2055,FDA,FDA-2007-D-0369,PSG_215344 - Draft Guidance on Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Sodium Chloride; Sodium Sulfate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:27:21Z,,1,0,09000064868293bf
FDA-2007-D-0369-2036,FDA,FDA-2007-D-0369,PSG_050777 - Draft Guidance on Tacrolimus,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:16:54Z,,1,0,090000648682937c
FDA-2007-D-0369-2037,FDA,FDA-2007-D-0369,PSG_083722 - Draft Guidance on Phytonadione,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:17:26Z,,1,0,090000648682937e
FDA-2007-D-0369-2054,FDA,FDA-2007-D-0369,PSG_215309 - Draft Guidance on Ruxolitinib Phosphate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:26:49Z,,1,0,09000064868293b6
FDA-2007-D-0369-2009,FDA,FDA-2007-D-0369,PSG_011745 - Draft Guidance on Phytonadione,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:53:37Z,,1,0,0900006486829327
FDA-2007-D-0369-2011,FDA,FDA-2007-D-0369,PSG_016084-Sus - Draft Guidance on Allopurinol,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:54:42Z,,1,0,090000648682932e
FDA-2007-D-0369-2028,FDA,FDA-2007-D-0369,PSG_021862 - Draft Guidance on Nepafenac,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:12:29Z,,1,0,0900006486829363
FDA-2007-D-0369-2065,FDA,FDA-2007-D-0369,PSG_218490 - Draft Guidance on Macitentan; Tadalafil,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:34:21Z,,1,0,09000064868293e0
FDA-2007-D-0369-2044,FDA,FDA-2007-D-0369,PSG_208558 - Draft Guidance on Olaparib,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:21:24Z,,1,0,0900006486829398
FDA-2007-D-0369-2034,FDA,FDA-2007-D-0369,PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:10Z,,1,0,0900006486829378
FDA-2007-D-0369-2031,FDA,FDA-2007-D-0369,PSG_022150 - Draft Guidance on Icatibant Acetate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:14:05Z,,1,0,0900006486829367
FDA-2007-D-0369-2032,FDA,FDA-2007-D-0369,PSG_022180 - Draft Guidance on Ferumoxytol,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:14:36Z,,1,0,0900006486829369
FDA-2007-D-0369-2030,FDA,FDA-2007-D-0369,PSG_020386 - Draft Guidance on Losartan Potassium,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:13:34Z,,1,0,0900006486829343
FDA-2007-D-0369-2047,FDA,FDA-2007-D-0369,PSG_211413 - Draft Guidance on Cefazolin Sodium,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:23:01Z,,1,0,090000648682939e
FDA-2007-D-0369-2043,FDA,FDA-2007-D-0369,PSG_206947 - Draft Guidance on Lenvatinib Mesylate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:20:49Z,,1,0,0900006486829396
FDA-2007-D-0369-2008,FDA,FDA-2007-D-0369,PSG_010104 - Draft Guidance on Phytonadione,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T19:53:05Z,,1,0,0900006486829325
FDA-2007-D-0369-2062,FDA,FDA-2007-D-0369,PSG_217064 - Draft Guidance on Phentolamine Mesylate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2024-11-21T21:32:46Z,,1,0,09000064868293d0
FDA-2007-D-0369-2017,FDA,FDA-2007-D-0369,PSG_020831 - Draft Guidance on Formoterol Fumarate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:07Z,,1,0,0900006486829347
FDA-2007-D-0369-2019,FDA,FDA-2007-D-0369,PSG_021077 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:14Z,,1,0,090000648682934b
FDA-2007-D-0369-2029,FDA,FDA-2007-D-0369,PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:10Z,,1,0,0900006486829365
FDA-2007-D-0369-2052,FDA,FDA-2007-D-0369,PSG_214324 - Draft Guidance on Treprostinil,Other,Guidance,2024-11-20T05:00:00Z,2024,11,2024-11-20T05:00:00Z,2025-01-22T04:59:59Z,2025-01-17T02:01:14Z,,1,0,09000064868293a8
FDA-2007-D-0369-2045,FDA,FDA-2007-D-0369,PSG_209830 - Draft Guidance on Aripiprazole Lauroxil,Other,Guidance,2024-11-20T00:00:00Z,2024,11,2024-11-20T00:00:00Z,2025-01-22T04:59:59Z,2025-05-09T01:17:15Z,,1,0,090000648682939a
FDA-2007-D-0369-2004,FDA,FDA-2007-D-0369,PSG_078690 - Draft Guidance on Carbidopa; Levodopa,Other,Guidance,2024-11-14T05:00:00Z,2024,11,2024-11-14T05:00:00Z,2024-12-31T04:59:59Z,2024-11-14T21:10:46Z,,1,0,090000648681414e
FDA-2007-D-0369-2003,FDA,FDA-2007-D-0369,PSG_011808 - Draft Guidance on Thioridazine Hydrochloride,Other,Guidance,2024-11-14T05:00:00Z,2024,11,2024-11-14T05:00:00Z,2024-12-31T04:59:59Z,2024-11-14T21:10:38Z,,1,0,09000064867f21ca
FDA-2007-D-0369-1995,FDA,FDA-2007-D-0369,PSG_209899 - Draft Guidance on Ozanimod Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T20:56:51Z,,1,0,09000064867f2d7d
FDA-2007-D-0369-1954,FDA,FDA-2007-D-0369,PSG_050759 - Draft Guidance on Mycophenolate Mofetil,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:37Z,,1,0,09000064867f240b
FDA-2007-D-0369-1972,FDA,FDA-2007-D-0369,PSG_083976 - Draft Guidance on Methyltestosterone,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:47Z,,1,0,09000064867f242f
FDA-2007-D-0369-1981,FDA,FDA-2007-D-0369,PSG_200175 - Draft Guidance on Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:53Z,,1,0,09000064867f2441
FDA-2007-D-0369-1983,FDA,FDA-2007-D-0369,PSG_201280 - Draft Guidance on Linagliptin,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:54Z,,1,0,09000064867f2445
FDA-2007-D-0369-1953,FDA,FDA-2007-D-0369,PSG_050725 - Draft Guidance on Amoxicillin; Clavulanate Potassium,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:36Z,,1,0,09000064867f2409
FDA-2007-D-0369-1986,FDA,FDA-2007-D-0369,PSG_201373 - Draft Guidance on Fexofenadine Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:56Z,,1,0,09000064867f244b
FDA-2007-D-0369-1957,FDA,FDA-2007-D-0369,PSG_050722 - Draft Guidance on Mycophenolate Mofetil,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:38Z,,1,0,09000064867f2411
FDA-2007-D-0369-1975,FDA,FDA-2007-D-0369,PSG_200534 - Draft Guidance on Oxycodone Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:49Z,,1,0,09000064867f2435
FDA-2007-D-0369-1889,FDA,FDA-2007-D-0369,PSG_022344 - Draft Guidance on Lamivudine; Tenofovir Disoproxil Fumara,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:44:53Z,,1,0,09000064867f237f
FDA-2007-D-0369-1941,FDA,FDA-2007-D-0369,PSG_050542 - Draft Guidance on Amoxicillin,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:11Z,,1,0,09000064867f23f1
FDA-2007-D-0369-1938,FDA,FDA-2007-D-0369,PSG_050662 - Draft Guidance on Clarithromycin,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:10Z,,1,0,09000064867f23eb
FDA-2007-D-0369-1893,FDA,FDA-2007-D-0369,PSG_022363 - Draft Guidance on Pitavastatin Calcium,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:44:57Z,,1,0,09000064867f2391
FDA-2007-D-0369-1936,FDA,FDA-2007-D-0369,PSG_050641-Cap-150MG - Draft Guidance on Doxycycline,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:08Z,,1,0,09000064867f23e7
FDA-2007-D-0369-1797,FDA,FDA-2007-D-0369,PSG_019915 - Draft Guidance on Fosinopril Sodium,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:25Z,,1,0,09000064867ee4fa
FDA-2007-D-0369-1817,FDA,FDA-2007-D-0369,PSG_020251 - Draft Guidance on Ranitidine Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:29Z,,1,0,09000064867f2123
FDA-2007-D-0369-1822,FDA,FDA-2007-D-0369,PSG_020180 - Draft Guidance on Finasteride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:32Z,,1,0,09000064867f212d
FDA-2007-D-0369-1832,FDA,FDA-2007-D-0369,PSG_020264 - Draft Guidance on Megestrol Acetate,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:33Z,,1,0,09000064867f2141
FDA-2007-D-0369-1836,FDA,FDA-2007-D-0369,PSG_020286 - Draft Guidance on Fosinopril Sodium; Hydrochlorothiazide,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:35Z,,1,0,09000064867f2149
FDA-2007-D-0369-1839,FDA,FDA-2007-D-0369,PSG_020297 - Draft Guidance on Carvedilol,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:35Z,,1,0,09000064867f214f
FDA-2007-D-0369-1843,FDA,FDA-2007-D-0369,PSG_020397 - Draft Guidance on Tizanidine Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:36Z,,1,0,09000064867f2157
FDA-2007-D-0369-1858,FDA,FDA-2007-D-0369,PSG_020528 - Draft Guidance on Trandolapril,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:39Z,,1,0,09000064867f2175
FDA-2007-D-0369-1871,FDA,FDA-2007-D-0369,PSG_020702 - Draft Guidance on Atorvastatin Calcium,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:42Z,,1,0,09000064867f2190
FDA-2007-D-0369-1876,FDA,FDA-2007-D-0369,PSG_020713 - Draft Guidance on Desogestrel; Ethinyl Estradiol,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:45Z,,1,0,09000064867f219a
FDA-2007-D-0369-1877,FDA,FDA-2007-D-0369,PSG_020717 - Draft Guidance on Modafinil,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:45Z,,1,0,09000064867f219c
FDA-2007-D-0369-1879,FDA,FDA-2007-D-0369,PSG_020658 - Draft Guidance on Ropinirole Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:45Z,,1,0,09000064867f21a0
FDA-2007-D-0369-1882,FDA,FDA-2007-D-0369,PSG_020636 - Draft Guidance on Nevirapine,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:46Z,,1,0,09000064867f21b0
FDA-2007-D-0369-1884,FDA,FDA-2007-D-0369,PSG_020704 - Draft Guidance on Loratadine,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T22:45:46Z,,1,0,09000064867f21b4
FDA-2007-D-0369-1944,FDA,FDA-2007-D-0369,PSG_050665 - Draft Guidance on Cefprozil,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-14T13:15:12Z,,1,0,09000064867f23f7
FDA-2007-D-0369-1991,FDA,FDA-2007-D-0369,PSG_009838 - Draft Guidance on Reserpine,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-13T16:42:38Z,,1,0,09000064867ee375
FDA-2007-D-0369-1802,FDA,FDA-2007-D-0369,PSG_019906 - Draft Guidance on Clomipramine Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-13T19:22:23Z,,1,0,09000064867f2105
FDA-2007-D-0369-1840,FDA,FDA-2007-D-0369,PSG_020448 - Draft Guidance on Loperamide Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-13T19:29:13Z,,1,0,09000064867f2151
FDA-2007-D-0369-1883,FDA,FDA-2007-D-0369,PSG_020667 - Draft Guidance on Pramipexole Dihydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-13T19:42:00Z,,1,0,09000064867f21b2
FDA-2007-D-0369-1897,FDA,FDA-2007-D-0369,PSG_022565 - Draft Guidance on Ibuprofen; Phenylephrine Hydrochloride,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2025-11-17T10:00:09Z,,1,0,09000064867f2399
FDA-2007-D-0369-1965,FDA,FDA-2007-D-0369,"PSG_083266 - Draft Guidance on Estrogens, Esterified",Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:43Z,,1,0,09000064867f2421
FDA-2007-D-0369-1966,FDA,FDA-2007-D-0369,PSG_050749 - Draft Guidance on Cefdinir,Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:44Z,,1,0,09000064867f2423
FDA-2007-D-0369-1950,FDA,FDA-2007-D-0369,"PSG_062279 - Draft Guidance on Griseofulvin, Microcrystalline; Griseofulvin, Microsize",Other,Guidance,2024-11-12T05:00:00Z,2024,11,2024-11-12T05:00:00Z,2024-12-31T04:59:59Z,2024-11-12T12:54:35Z,,1,0,09000064867f2403